Loading the stock brief
Stock brief · the live tape
SOPHSOPHiA GENETICS SA
Health Care · Health Care Equipment & Services · Nasdaq
$7.41
▼ $0.27 (-3.5%) · 30dclose Friday, October 9, 2026
No member of Congress has disclosed a trade in this ticker.
190 insider filings · 3 tracked funds
The Hillno disclosed congressional trade
The Boardroom
▲ 1▼ 147
1 buys · 147 sells · 190 filingsFeeding Time
▲ 2▼ 0
2 adding · 0 trimming · 3 holdingCAT Scan
53Only one filer stands behind this number, and it is barely off 50.
- Insiders▲1 insider bought in the open market, latest 5 Jun
- Funds·Nothing counted in the last year
- Congress·Nothing counted in the last year
Quiet since 5 Jun
Scored 15 Oct · From public filings. Not a forecast. How it works
The tape
Price with a twin dot per disclosed trade: filled at the trade, hollow at the filing. The dashed gap is what the market did in between, not anyone’s return.
trade (insider)
The boardroom
Scheduled 10b5-1 sales are usually noise, set on autopilot months ago. The unscheduled ones are the ones to read.
Camblong JurgiExecutive Chairman, DirectorScheduled · 10b5-1
Puylaert KevinChief Sales OfficerUnscheduled
Valente ManuelaChief People OfficerScheduled · 10b5-1
Van Well DaanChief Legal OfficerScheduled · 10b5-1
Menu PhilippeChief Medical OfficerScheduled · 10b5-1
Muken RossChief Executive Officer, DirectorScheduled · 10b5-1
Puylaert KevinChief Sales OfficerUnscheduled
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
CARDOZA GEORGEChief Financial OfficerScheduled · 10b5-1
Verma AbhimanyuChief Technology OfficerScheduled · 10b5-1
Muken RossChief Executive Officer, DirectorScheduled · 10b5-1
CARDOZA GEORGEChief Financial OfficerScheduled · 10b5-1
Menu PhilippeChief Medical OfficerScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Van Well DaanChief Legal OfficerScheduled · 10b5-1
Camblong JurgiExecutive Chairman, DirectorScheduled · 10b5-1
HIBBS KATHY LDirectorScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Menu PhilippeChief Medical OfficerScheduled · 10b5-1
HIBBS KATHY LDirectorScheduled · 10b5-1
Verma AbhimanyuChief Technology OfficerScheduled · 10b5-1
Verma AbhimanyuChief Technology OfficerScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Valente ManuelaChief People OfficerScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Valente ManuelaChief People OfficerScheduled · 10b5-1
Valente ManuelaChief People OfficerScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Menu PhilippeChief Medical OfficerScheduled · 10b5-1
Camblong JurgiExecutive Chairman, DirectorScheduled · 10b5-1
Verma AbhimanyuChief Technology OfficerScheduled · 10b5-1
Camblong JurgiExecutive Chairman, DirectorScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerUnscheduled
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
Xu ZhenyuChief Scientific OfficerScheduled · 10b5-1
The fund book
Tracked 13F holders and how their position moved, quarter over quarter.
Akre Capital Management LLC$21.5M3.7M sharesheldRenaissance Technologies LLC$654K113K sharesaddedCitadel Advisors LLC$222K38K sharesnew position
Positions as filed for the quarter ending 30 Jun 2026, the latest on file. A 13F is a quarter-end photograph filed up to 45 days later, so this is where these funds stood then, not what they hold now. Common stock only: options and short positions are not in a 13F, and a fund that had already sold out does not appear.
⚠️ Public information, sourced from STOCK Act, Form 4 and 13F filings. Ranges use midpoints. Price paths between a trade and its filing are market moves, not anyone’s return. Not financial advice.